{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:28:09Z","timestamp":1785356889299,"version":"3.55.0"},"reference-count":226,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.prp.2023.154809","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:10:47Z","timestamp":1694815847000},"page":"154809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression"],"prefix":"10.1016","volume":"251","author":[{"given":"Meysam","family":"Ramezani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Zobeiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Abdolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Baghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2008.08.012","article-title":"Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet","volume":"49","author":"Ahn","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2023.154809_bib3","doi-asserted-by":"crossref","unstructured":"Ahrens, M., Ammerpohl, O., von Sch\u00f6nfels, W., Kolarova, J., Bens, S., Itzel, T.,. Hinrichsen, H.J. C. m. (2013b). DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. 18(2), 296\u2013302.","DOI":"10.1016\/j.cmet.2013.07.004"},{"key":"10.1016\/j.prp.2023.154809_bib4","doi-asserted-by":"crossref","unstructured":"Ajmo, J.M., Liang, X., Rogers, C.Q., Pennock, B., You, M.J. A.J. o P.-G., & Physiology, L. (2008). Resveratrol alleviates alcoholic fatty liver in mice. 295(4), G833-G842.","DOI":"10.1152\/ajpgi.90358.2008"},{"key":"10.1016\/j.prp.2023.154809_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.665987","article-title":"Gene-environmental interactions as metabolic drivers of nonalcoholic steatohepatitis","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2023.154809_bib6","doi-asserted-by":"crossref","unstructured":"Alisi, A., Da Sacco, L., Bruscalupi, G., Piemonte, F., Panera, N., De Vito, R.,. Nobili, V.J. L. i (2011). Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. 91(2), 283\u2013293.","DOI":"10.1038\/labinvest.2010.166"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.117.242081","article-title":"Pleiotropic and adverse effects of statins-do epigenetics play a role?","volume":"362","author":"Allen","year":"2017","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2023.154809_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.114067","article-title":"Measuring acetyl-CoA and acetylated histone turnover in vivo: Effect of a high fat diet","volume":"615","author":"Arias-Alvarado","year":"2021","journal-title":"Anal. Biochem"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/hep.29034","article-title":"A liver\u2010specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis","volume":"66","author":"Atanasovska","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.prp.2023.154809_bib11","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/jcm4121953","article-title":"MicroRNAs in nonalcoholic fatty liver disease","volume":"4","author":"Baffy","year":"2015","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib12","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug\u2010induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2023.154809_bib13","doi-asserted-by":"crossref","unstructured":"Barger, J.L., Kayo, T., Vann, J.M., Arias, E.B., Wang, J., Hacker, T.A.,. Leeuwenburgh, C.J. P. o. (2008). A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. 3(6), e2264.","DOI":"10.1371\/journal.pone.0002264"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154809_bib15","doi-asserted-by":"crossref","unstructured":"Basaranoglu, M., Basaranoglu, G., Sabuncu, T., & Sent\u00fcrk, H.J. W. j. o. g. W. (2013). Fructose as a key player in the development of fatty liver disease. 19(8), 1166.","DOI":"10.3748\/wjg.v19.i8.1166"},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.tig.2020.03.003","article-title":"The epigenetic drug discovery landscape for metabolic-associated fatty liver disease","volume":"36","author":"Bayoumi","year":"2020","journal-title":"Trends Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154809_bib17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/cmdc.201300534","article-title":"Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease","volume":"9","author":"Bhan","year":"2014","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04361-y","article-title":"The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity","volume":"9","author":"Bricambert","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154809_bib19","doi-asserted-by":"crossref","unstructured":"Bricambert, J., Alves-Guerra, M.-C., Esteves, P., Prip-Buus, C., Bertrand-Michel, J., Guillou, H.,. Mathurin, P.J. N. c. (2018b). The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. 9(1), 1\u201318.","DOI":"10.1038\/s41467-018-04361-y"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: from molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.prp.2023.154809_bib21","doi-asserted-by":"crossref","unstructured":"Brown, M.S., & Goldstein, J.L. J.C. m. (2008). Selective versus total insulin resistance: a pathogenic paradox. 7(2), 95\u201396.","DOI":"10.1016\/j.cmet.2007.12.009"},{"key":"10.1016\/j.prp.2023.154809_bib22","doi-asserted-by":"crossref","unstructured":"Byun, S., Seok, S., Kim, Y.-C., Zhang, Y., Yau, P., Iwamori, N.,. Kemper, J.K. J. N. c. (2020). Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. 11(1), 1\u201315.","DOI":"10.1038\/s41467-020-14384-z"},{"key":"10.1016\/j.prp.2023.154809_bib23","doi-asserted-by":"crossref","unstructured":"C.D. Byrne G.J.J. Targher o. h NAFLD: a multisystem Dis. 62 1 2015 S47 S64.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"10.1016\/j.prp.2023.154809_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154140","article-title":"Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin \u03b18-mediated activation of RhoA signaling pathway","volume":"104","author":"Cai","year":"2020","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154809_bib26","doi-asserted-by":"crossref","unstructured":"Calvanese, V., Lara, E., Kahn, A., & Fraga, M.F. J.A. r. r. (2009). The role of epigenetics in aging and age-related diseases. 8(4), 268\u2013276.","DOI":"10.1016\/j.arr.2009.03.004"},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113372","article-title":"Impact of long-term supplementation with fish oil in individuals with non-alcoholic fatty liver disease: a double blind randomized placebo controlled clinical trial","volume":"12","author":"Cansan\u00e7\u00e3o","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib28","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2013.07.011","article-title":"Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation","volume":"59","author":"Cao","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2023.154809_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.931928","article-title":"Identifying autophagy-related lncRNAs and potential ceRNA networks in NAFLD","volume":"13","author":"Cao","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154809_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00719","article-title":"Glucagon like peptide 1 and MicroRNA in metabolic diseases: focusing on GLP1 action on miRNAs","volume":"9","author":"Capuani","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2023.154809_bib31","doi-asserted-by":"crossref","unstructured":"Carter, S., Li, Z., Lemieux, I., Alm\u00e9ras, N., Tremblay, A., Bergeron, J.,. Picard, F.J. A. (2014). Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides. 237(2), 645\u2013651.","DOI":"10.1016\/j.atherosclerosis.2014.09.022"},{"issue":"10","key":"10.1016\/j.prp.2023.154809_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101363","article-title":"Genome profiling of H3k4me3 histone modification in human adipose tissue during obesity and insulin resistance","volume":"9","author":"Castellano-Castillo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2023.154809_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"13","key":"10.1016\/j.prp.2023.154809_bib34","first-page":"1753","article-title":"Tissue-specific regulation of SIRT1 by calorie restriction","volume":"22","author":"Chen","year":"2008","journal-title":"development"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib35","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41418-023-01183-4","article-title":"GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib36","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1080\/21655979.2021.1960463","article-title":"Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2","volume":"12","author":"Chen","year":"2021","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010021","article-title":"Long non-coding RNA profiling in a non-alcoholic fatty liver disease rodent model: new insight into pathogenesis","volume":"18","author":"Chen","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s13577-021-00593-1","article-title":"Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression","volume":"34","author":"Cheng","year":"2021","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/C8MO00214B","article-title":"Gene expression profile-based drug screen identifies SAHA as a novel treatment for NAFLD","volume":"15","author":"Cheng","year":"2019","journal-title":"Mol. Omics"},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib40","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2023.154809_bib41","first-page":"1","article-title":"microRNA-103a-3p promotes inflammation and fibrosis in nonalcoholic fatty liver disease by targeting HBP1","author":"Chu","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119239","article-title":"MiR-182-5p is upregulated in hepatic tissues from a diet-induced NAFLD\/NASH\/HCC C57BL\/6J mouse model and modulates cyld and Foxo1 expression","volume":"24","author":"Compagnoni","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154809_bib43","article-title":"Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p\/CPT1B axis","volume":"127","author":"Dang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib44","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI127502","article-title":"Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice","volume":"130","author":"De Jesus","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-019-3307-2","article-title":"Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software","volume":"21","author":"Decamps","year":"2020","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.prp.2023.154809_bib46","doi-asserted-by":"crossref","unstructured":"Di Francesco, A., Di Germanio, C., Bernier, M., & De Cabo, R.J. S. (2018). A time to fast. 362(6416), 770\u2013775.","DOI":"10.1126\/science.aau2095"},{"key":"10.1016\/j.prp.2023.154809_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib48","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1007\/s11033-022-07515-w","article-title":"MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1","volume":"49","author":"Ding","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"e000631","key":"10.1016\/j.prp.2023.154809_bib49","article-title":"Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis","volume":"Vol. 4","author":"DiNicolantonio","year":"2017","journal-title":": Arch. Dis. Child."},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib50","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","article-title":"Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis","volume":"29","author":"Dobie","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2023.154809_bib51","volume":"2015","author":"Dongiovanni","year":"2015"},{"issue":"12","key":"10.1016\/j.prp.2023.154809_bib52","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.3390\/ijms19123966","article-title":"miRNA signature in NAFLD: a turning point for a non-invasive diagnosis","volume":"19","author":"Dongiovanni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/cells8080845","article-title":"Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)","volume":"8","author":"Drescher","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-016-0926-5","article-title":"Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK","volume":"53","author":"Du","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1499-3872(17)60006-7","article-title":"Remote ischemic preconditioning protects liver ischemia-reperfusion injury by regulating eNOS-NO pathway and liver microRNA expressions in fatty liver rats","volume":"16","author":"Duan","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int"},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib56","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease\u2010specific mortality in NAFLD after up to 33 years of follow\u2010up.","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.prp.2023.154809_bib57","doi-asserted-by":"crossref","first-page":"17644","DOI":"10.3390\/ijms151017644","article-title":"Circulating RNA molecules as biomarkers in liver disease","volume":"15","author":"Enache","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154809_bib58","doi-asserted-by":"crossref","unstructured":"Erion, D.M., Yonemitsu, S., Nie, Y., Nagai, Y., Gillum, M.P., Hsiao, J.J.,. Yu, X.X. J.P. o. t. N. A. o. S. (2009). SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. 106(27), 11288\u201311293.","DOI":"10.1073\/pnas.0812931106"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib59","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0699-3","article-title":"Role of long non-coding RNAs in glucose metabolism in cancer","volume":"16","author":"Fan","year":"2017","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/hepr.13330","article-title":"Inhibition of microRNA\u2010124a attenuates non\u2010alcoholic fatty liver disease through upregulation of adipose triglyceride lipase and the effect of liraglutide intervention","volume":"49","author":"Fang","year":"2019","journal-title":"Hepatol. Res."},{"issue":"6022","key":"10.1016\/j.prp.2023.154809_bib62","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1198125","article-title":"A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism","volume":"331","author":"Feng","year":"2011","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.prp.2023.154809_bib63","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/biom12121773","article-title":"Ornithine aspartate and vitamin-e combination has beneficial effects on cardiovascular risk factors in an animal model of nonalcoholic fatty liver disease in rats","volume":"12","author":"de Freitas","year":"2022","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib64","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cgh.2018.11.037","article-title":"Liver fat is associated with markers of inflammation and oxidative stress in analysis of data from the Framingham heart study","volume":"17","author":"Fricker","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib65","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.prp.2023.154809_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092167","article-title":"Adverse maternal environments perturb hepatic DNA methylome and transcriptome prior to the adult-onset non-alcoholic fatty liver disease in mouse offspring","volume":"15","author":"Fu","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib68","first-page":"549","article-title":"The epigenetic landscape of age-related diseases: the geroscience perspective","volume":"18","author":"Gensous","year":"2017"},{"key":"10.1016\/j.prp.2023.154809_bib69","doi-asserted-by":"crossref","unstructured":"Gensous, N., Franceschi, C., Santoro, A., Milazzo, M., Garagnani, P., & Bacalini, M.G. J.I. j. o. m. s. (2019). The impact of caloric restriction on the epigenetic signatures of aging. 20(8), 2022.","DOI":"10.3390\/ijms20082022"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0525-9","article-title":"Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways","volume":"10","author":"Gerhard","year":"2018","journal-title":"Clin. Epigenetics"},{"issue":"12","key":"10.1016\/j.prp.2023.154809_bib71","first-page":"3235","article-title":"SirT1 regulates adipose tissue inflammation","volume":"60","author":"Gillum","year":"2011"},{"issue":"47","key":"10.1016\/j.prp.2023.154809_bib72","doi-asserted-by":"crossref","first-page":"E5023","DOI":"10.1073\/pnas.1415098111","article-title":"H19 long noncoding RNA controls the mRNA decay promoting function of KSRP","volume":"111","author":"Giovarelli","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2023.154809_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110190","article-title":"LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p\/ROCK1 axis","volume":"90","author":"Guo","year":"2022","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib74","first-page":"1","article-title":"Ultraconserved element uc. 372 drives hepatic lipid accumulation by suppressing miR-195\/miR4668 maturation","volume":"9","author":"Guo","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3748\/wjg.v24.i3.323","article-title":"circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling","volume":"24","author":"Guo","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib76","first-page":"1","article-title":"Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism","volume":"18","author":"Hahn","year":"2017","journal-title":"G. b."},{"key":"10.1016\/j.prp.2023.154809_bib77","doi-asserted-by":"crossref","unstructured":"Hall, K.D., Ayuketah, A., Brychta, R., Cai, H., Cassimatis, T., Chen, K.Y.,. Darcey, V.J. C. m (2019). Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. 30(1), 67\u201377. e63.","DOI":"10.1016\/j.cmet.2019.05.008"},{"key":"10.1016\/j.prp.2023.154809_bib78","doi-asserted-by":"crossref","unstructured":"Hanouskov\u00e1, B., Nepra\u0161ov\u00e1, B., Sk\u00e1lov\u00e1, L., Malet\u00ednsk\u00e1, L., Zemanov\u00e1, K., Ambro\u017e, M., & Matou\u0161kov\u00e1, P.J. T.J. o N.B. (2019). High-fructose drinks affect microRNAs expression differently in lean and obese mice. 68, 42\u201350.","DOI":"10.1016\/j.jnutbio.2019.03.001"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib79","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib80","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","article-title":"A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study","volume":"5","author":"Harrison","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"sup2","key":"10.1016\/j.prp.2023.154809_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/21691401.2018.1453830","article-title":"Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD","volume":"46","author":"He","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib82","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/cr.2011.23","article-title":"Regulation and function of DNA methylation in plants and animals","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2023.154809_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-31886-5","article-title":"Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease","volume":"8","author":"Hotta","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib85","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11010-021-04269-0","article-title":"Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p\/GRIA3","volume":"477","author":"Hu","year":"2022","journal-title":"Mol. Cell Biochem"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib87","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41401-021-00725-1","article-title":"Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis","volume":"43","author":"Huang","year":"2022","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.prp.2023.154809_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2019.01.018","article-title":"LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6","volume":"94","author":"Huang","year":"2019","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib89","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"21","key":"10.1016\/j.prp.2023.154809_bib90","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.3390\/ijms21218138","article-title":"DNA methylation in nonalcoholic fatty liver disease","volume":"21","author":"Hyun","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib91","article-title":"Systematic analysis of long non-coding RNA genes in nonalcoholic fatty liver disease","volume":"8","author":"Ilieva","year":"2022","journal-title":"Noncoding RNA"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/2211536607666180531093302","article-title":"Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD)","volume":"7","author":"Jampoka","year":"2018","journal-title":"Microrna"},{"key":"10.1016\/j.prp.2023.154809_bib93","doi-asserted-by":"crossref","unstructured":"Jia, Y., Cong, R., Li, R., Yang, X., Sun, Q., Parvizi, N., & Zhao, R.J. T.J. o. n. (2012). Maternal low-protein diet induces gender-dependent changes in epigenetic regulation of the glucose-6-phosphatase gene in newborn piglet liver. 142(9), 1659\u20131665.","DOI":"10.3945\/jn.112.160341"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib94","article-title":"Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: diagnostic and mechanistic relevance","volume":"4","author":"Johnson","year":"2022","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-021-01129-y","article-title":"Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD","volume":"13","author":"Johnson","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.prp.2023.154809_bib96","doi-asserted-by":"crossref","unstructured":"Jou, J., Choi, S.S., & Diehl, A.M. (2008). Mechanisms of disease progression in nonalcoholic fatty liver disease. Paper presented at the Seminars in liver disease.","DOI":"10.1055\/s-0028-1091981"},{"key":"10.1016\/j.prp.2023.154809_bib97","doi-asserted-by":"crossref","unstructured":"Kammel, A., Saussenthaler, S., J\u00e4hnert, M., Jonas, W., Stirm, L., Hoeflich, A.,. Joost, H.-G. J. H. m. g. (2016). Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice. 25(12), 2588\u20132599.","DOI":"10.1093\/hmg\/ddw121"},{"issue":"20","key":"10.1016\/j.prp.2023.154809_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011085","article-title":"Histone demethylase KDM7A contributes to the development of hepatic steatosis by targeting diacylglycerol acyltransferase 2","volume":"22","author":"Kim","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2015.02.049","article-title":"Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease","volume":"63","author":"Kitamoto","year":"2015","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib101","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of NAFLD and NASH in adults and children","volume":"20","author":"Kleiner","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib102","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/cimb44030075","article-title":"DNA methylation patterns according to fatty liver index and longitudinal changes from the korean genome and epidemiology study (KoGES)","volume":"44","author":"Ko","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib103","doi-asserted-by":"crossref","first-page":"816","DOI":"10.4161\/epi.25430","article-title":"Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis","volume":"8","author":"Koestler","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.prp.2023.154809_bib104","doi-asserted-by":"crossref","unstructured":"Kotas, M.E., Gorecki, M.C., & Gillum, M.P. J.A. (2013). Sirtuin-1 is a nutrient-dependent modulator of inflammation. 2(2), 113\u2013118.","DOI":"10.4161\/adip.23437"},{"issue":"12","key":"10.1016\/j.prp.2023.154809_bib105","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1530\/EC-18-0499","article-title":"Reduced expression of thyroid hormone receptor \u03b2 in human nonalcoholic steatohepatitis","volume":"7","author":"Krause","year":"2018","journal-title":"Endocr. Connect."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib106","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells8050503","article-title":"Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis","volume":"8","author":"Krenkel","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib107","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/epi.15.55","article-title":"Long noncoding RNAs in human disease: emerging mechanisms and therapeutic strategies","volume":"7","author":"Lalev\u00e9e","year":"2015","journal-title":"Epigenomics"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.05.019","article-title":"HCF-1 regulates de novo lipogenesis through a nutrient-sensitive complex with ChREBP","volume":"75","author":"Lane","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2023.154809_bib109","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mam.2016.11.008","article-title":"Epigenetics in non-alcoholic fatty liver disease","volume":"54","author":"Lee","year":"2017","journal-title":"Mol. Asp. Med."},{"issue":"9","key":"10.1016\/j.prp.2023.154809_bib110","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41401-020-00571-7","article-title":"3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity","volume":"42","author":"Lee","year":"2021","journal-title":"Acta Pharm. Sin."},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib111","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/nu6083303","article-title":"Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition","volume":"6","author":"Lee","year":"2014","journal-title":"Nutrients"},{"issue":"R1","key":"10.1016\/j.prp.2023.154809_bib112","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1093\/hmg\/dds317","article-title":"Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy","volume":"21","author":"Lee","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib113","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","article-title":"The role of chromatin during transcription","volume":"128","author":"Li","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113631","article-title":"MicroRNA-574\u20135p targeting HOXC6 expression inhibits the hepatocyte lipid uptake to alleviate non-alcoholic fatty liver disease","volume":"428","author":"Li","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib115","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181722","article-title":"LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a\/PPAR\u03b3 axis in non-alcoholic fatty liver disease.","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib116","article-title":"A computational framework to infer human disease-associated long noncoding RNAs","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2023.154809_bib117","article-title":"MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/carcin\/bgn270","article-title":"The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells","volume":"30","author":"Lorenzo","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2023.154809_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: mayo Clinic experiences with a hitherto unnamed disease","author":"Ludwig","year":"1980","journal-title":"Pap. Presente Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jcmgh.2022.08.011","article-title":"DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic Steatosis","volume":"14","author":"Luo","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2023.154809_bib121","doi-asserted-by":"crossref","unstructured":"Luo, X., He, Z., Sun, X., Gu, X., Zhang, W., Gao, J.,. therapy. (2020). DHA protects against hepatic steatosis by activating Sirt1 in a high fat diet-induced nonalcoholic fatty liver disease mouse model. 13, 185.","DOI":"10.2147\/DMSO.S232279"},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib122","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2337\/db18-1193","article-title":"A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease","volume":"68","author":"Ma","year":"2019","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib123","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1194\/jlr.RA120000664","article-title":"The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice [S]","volume":"61","author":"Ma","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prp.2023.154809_bib124","doi-asserted-by":"crossref","unstructured":"Ma, Z., Deng, C., Hu, W., Zhou, J., Fan, C., Di, S.,. Wang, D.J. C. i. i. m. b. (2017). Liver X receptors and their agonists: targeting for cholesterol homeostasis and cardiovascular diseases. 22(1), 41\u201364.","DOI":"10.21775\/cimb.022.041"},{"key":"10.1016\/j.prp.2023.154809_bib125","doi-asserted-by":"crossref","unstructured":"Martins, I., Creegan, R., Lim, W., & Martins, R. (2013). Molecular insights into appetite control and neuroendocrine disease as risk factors for chronic diseases in Western countries.","DOI":"10.4236\/ojemd.2013.35A002"},{"key":"10.1016\/j.prp.2023.154809_bib126","unstructured":"Martins, I.J. (2013). Increased risk for obesity and diabetes with neurodegeneration in developing countries."},{"key":"10.1016\/j.prp.2023.154809_bib127","doi-asserted-by":"crossref","unstructured":"Martins, I.J. (2014). Induction of NAFLD with increased risk of obesity and chronic diseases in developed countries.","DOI":"10.4236\/ojemd.2014.44011"},{"key":"10.1016\/j.prp.2023.154809_bib128","doi-asserted-by":"crossref","unstructured":"Martins, I.J., & Creegan, R. (2014). Links between insulin resistance, lipoprotein metabolism and amyloidosis in Alzheimer's Disease.","DOI":"10.4236\/health.2014.612190"},{"key":"10.1016\/j.prp.2023.154809_bib129","doi-asserted-by":"crossref","unstructured":"Martins, I.J., Lim, W.L. F., Wilson, A.C., Laws, S.M., & Martins, R.N. (2013). The acceleration of aging and Alzheimer\u2019s disease through the biological mechanisms behind obesity and type II diabetes.","DOI":"10.4236\/health.2013.55121"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031113","article-title":"The epigenetics of the endocannabinoid system","volume":"21","author":"Meccariello","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib132","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/15592294.2017.1294305","article-title":"Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action","volume":"12","author":"de Mello","year":"2017","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib133","first-page":"607","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"Mihaylova","year":"2011"},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib134","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3892\/ijmm.2014.1958","article-title":"Obesity increases histone H3 lysine 9 and 18 acetylation at Tnfa and Ccl2 genes in mouse liver","volume":"34","author":"Mikula","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib135","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301902","article-title":"Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis","volume":"6","author":"Miyagawa","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.prp.2023.154809_bib136","article-title":"Paper presented at the seminars in liver disease","author":"Mohr","year":"2015","journal-title":"Overv. Micro Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib138","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.13770","article-title":"Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference","volume":"44","author":"Munteanu","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib139","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbalip.2016.12.005","article-title":"NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition","volume":"1862","author":"Mwinyi","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib141","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cell.2008.07.002","article-title":"The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control","volume":"134","author":"Nakahata","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154809_bib142","doi-asserted-by":"crossref","unstructured":"Nemoto, S., Fergusson, M.M., & Finkel, T.J. J. o B.C. (2005). SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1\u03b1. 280(16), 16456\u201316460.","DOI":"10.1074\/jbc.M501485200"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib143","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.prp.2023.154809_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109084","article-title":"Serum microRNA levels as a biomarker for diagnosing non-alcoholic fatty liver disease in chinese colorectal polyp patients","volume":"24","author":"Ng","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.27153","article-title":"Inhibition of microRNA\u201024 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.","volume":"60","author":"Ng","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib146","first-page":"2636","article-title":"Comprehensive circular RNA expression profiles in a mouse model of nonalcoholic steatohepatitis","volume":"19","author":"Ou","year":"2019","journal-title":"Mol. Med Rep."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib147","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: Current burden and expected challenges","volume":"65","author":"Pais","year":"2016","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib148","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.dld.2021.05.013","article-title":"Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters","volume":"54","author":"Pan","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.prp.2023.154809_bib149","doi-asserted-by":"crossref","unstructured":"Parsanathan, R., & Jain, S.K. J.S. R. (2019). Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice. 9(1), 1\u201311.","DOI":"10.1038\/s41598-019-51377-5"},{"key":"10.1016\/j.prp.2023.154809_bib150","article-title":"Offspring NAFLD liver phospholipid profiles are differentially programmed by maternal high-fat diet and maternal one carbon supplement","volume":"111","author":"Peng","year":"2022","journal-title":"J. Nutr. Biochem"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib151","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","article-title":"METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.","volume":"30","author":"Peng","year":"2022","journal-title":"Mol. Ther."},{"issue":"22","key":"10.1016\/j.prp.2023.154809_bib152","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.3390\/ijms20225613","article-title":"The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: screening issue and future perspectives","volume":"20","author":"Pennisi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib153","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154809_bib154","doi-asserted-by":"crossref","unstructured":"Ponugoti, B., Fang, S., & Kemper, J.K. J.M. E. (2007). Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c. 21(11), 2698\u20132712.","DOI":"10.1210\/me.2007-0196"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab."},{"issue":"7783","key":"10.1016\/j.prp.2023.154809_bib156","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib157","first-page":"601","article-title":"Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression","volume":"66","author":"Ramirez","year":"2017","journal-title":"J. o. H."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib158","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.21608\/ejhm.2022.230277","article-title":"The expression level of long non-coding RNA PVT1 as a diagnostic marker for advanced stages in patients with nonalcoholic fatty liver disease","volume":"87","author":"Rashad","year":"2022","journal-title":"Egypt. J. Hosp. Med."},{"key":"10.1016\/j.prp.2023.154809_bib159","doi-asserted-by":"crossref","unstructured":"Rodgers, J.T., & Puigserver, P.J. P. o t N.A. o S. (2007). Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. 104(31), 12861\u201312866.","DOI":"10.1073\/pnas.0702509104"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib160","first-page":"177","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"C. p."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib161","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib162","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-05049-w","article-title":"miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells","volume":"6","author":"Sakai","year":"2023","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib163","first-page":"1","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"C. H. R."},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib164","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.0808180106","article-title":"Adverse metabolic and cardiovascular consequences of circadian misalignment","volume":"106","author":"Scheer","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.prp.2023.154809_bib165","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41591-019-0660-7","article-title":"Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression","volume":"25","author":"Segovia-Miranda","year":"2019","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib166","first-page":"3144","article-title":"Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid \u03b2-oxidation","volume":"128","author":"Seok","year":"2018","journal-title":"o. C. i."},{"issue":"9","key":"10.1016\/j.prp.2023.154809_bib167","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/db21-1145","article-title":"Long noncoding RNA lncRHL regulates hepatic VLDL secretion by modulating hnRNPU\/BMAL1\/MTTP axis","volume":"71","author":"Shen","year":"2022","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib168","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1751-2980.2009.00416.x","article-title":"SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells","volume":"11","author":"Shi","year":"2010","journal-title":"J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-29993-4","article-title":"Analysis of diet-induced differential methylation, expression, and interactions of lncRNA and protein-coding genes in mouse liver","volume":"8","author":"Silva","year":"2018","journal-title":"Sci. Rep."},{"issue":"36","key":"10.1016\/j.prp.2023.154809_bib170","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: a review","volume":"23","author":"Singh","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2023.154809_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib172","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23927","article-title":"Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator\u2013activated receptor \u03b3 coactivator 1\u03b1 promoter","volume":"52","author":"Sookoian","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib173","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prp.2023.154809_bib174","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib175","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5219","article-title":"Gene therapy targeting miR\u2011212\u20133p exerts therapeutic effects on MAFLD similar to those of exercise","volume":"51","author":"Sun","year":"2023","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.prp.2023.154809_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101603","article-title":"Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice","volume":"66","author":"Sun","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.prp.2023.154809_bib177","article-title":"Potential blood DNA methylation biomarker genes for diagnosis of liver fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease","volume":"9","author":"Sun","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.prp.2023.154809_bib178","doi-asserted-by":"crossref","unstructured":"Sundqvist, A., & Ericsson, J.J. P. o t N.A. o S. (2003). Transcription-dependent degradation controls the stability of the SREBP family of transcription factors. 100(24), 13833\u201313838.","DOI":"10.1073\/pnas.2335135100"},{"key":"10.1016\/j.prp.2023.154809_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-med-051215-031109","article-title":"Nonalcoholic steatohepatitis","volume":"68","author":"Suzuki","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.prp.2023.154809_bib180","doi-asserted-by":"crossref","unstructured":"Ter Horst, K.W., & Serlie, M.J. J.N. (2017). Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. 9(9), 981.","DOI":"10.3390\/nu9090981"},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib181","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2217\/epi-2016-0153","article-title":"Cell-type deconvolution in epigenome-wide association studies: a review and recommendations","volume":"9","author":"Teschendorff","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.prp.2023.154809_bib182","unstructured":"Thakur, V.S., Gupta, K., & Gupta, S.J. I. j. o. o. (2012). Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. 41(1), 353\u2013361."},{"issue":"7642","key":"10.1016\/j.prp.2023.154809_bib183","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature21365","article-title":"Adipose-derived circulating miRNAs regulate gene expression in other tissues","volume":"542","author":"Thomou","year":"2017","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.prp.2023.154809_bib184","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1158\/0008-5472.CAN-14-3786","article-title":"Histone deacetylase HDAC8 promotes insulin resistance and \u03b2-catenin activation in NAFLD-associated hepatocellular carcinoma","volume":"75","author":"Tian","year":"2015","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib185","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/hep.30559","article-title":"Hepatic interferon regulatory factor 6 alleviates liver steatosis and metabolic disorder by transcriptionally suppressing peroxisome proliferator\u2010activated receptor \u03b3 in mice","volume":"69","author":"Tong","year":"2019","journal-title":"Hepatology"},{"issue":"36","key":"10.1016\/j.prp.2023.154809_bib186","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"16","key":"10.1016\/j.prp.2023.154809_bib187","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.prp.2023.154809_bib188","first-page":"1403","article-title":"Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid\/cholesterol regulator SREBP","volume":"24","author":"Walker","year":"2010","journal-title":"development"},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib189","first-page":"596","article-title":"A hormone-dependent module regulating energy balance","volume":"145","author":"Wang","year":"2011"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib190","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/jcmm.14818","article-title":"Long non\u2010coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib191","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1214\/16-AOS1511","article-title":"Confounder adjustment in multiple hypothesis testing","volume":"45","author":"Wang","year":"2017","journal-title":"Ann. Stat."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib192","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/db17-0799","article-title":"Long noncoding RNA lncSHGL recruits hnRNPA1 to suppress hepatic gluconeogenesis and lipogenesis","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib193","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2020.11.028","article-title":"Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance","volume":"74","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib194","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcb.26317","article-title":"Down\u2010regulation of lncRNA\u2010NEAT1 alleviated the non\u2010alcoholic fatty liver disease via mTOR\/S6K1 signaling pathway","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2023.154809_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120925","article-title":"MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes","volume":"308","author":"Wang","year":"2022","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154809_bib196","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1159\/000485765","article-title":"MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via yin yang 1","volume":"44","author":"Wu","year":"2017","journal-title":"Cell Physiol. Biochem"},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib197","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154809_bib198","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.12659\/MSM.909747","article-title":"Altered DNA methylation sites in peripheral blood leukocytes from patients with simple steatosis and nonalcoholic steatohepatitis (NASH)","volume":"24","author":"Wu","year":"2018","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib199","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.livres.2020.08.003","article-title":"The progress of epigenetics in the development and progression of non-alcoholic fatty liver disease","volume":"4","author":"Xu","year":"2020","journal-title":"Liver Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib200","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1210\/en.2009-1013","article-title":"Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+\/\u2212 mice: a role of lipid mobilization and inflammation","volume":"151","author":"Xu","year":"2010","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.prp.2023.154809_bib201","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2337\/db14-0263","article-title":"SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis","volume":"63","author":"Xu","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.prp.2023.154809_bib202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2022.04.008","article-title":"CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis","volume":"610","author":"Xu","year":"2022","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2023.154809_bib203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"23","key":"10.1016\/j.prp.2023.154809_bib204","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.18632\/aging.104081","article-title":"Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179\/miR-188-3p\/GPX4 signaling","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.prp.2023.154809_bib205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fgene.2015.00145","article-title":"Long noncoding RNAs: a potential novel class of cancer biomarkers","volume":"6","author":"Yarmishyn","year":"2015","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib206","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib207","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00335-022-09945-0","article-title":"RMRP inhibition prevents NAFLD progression in rats via regulating miR-206\/PTPN1 axis","volume":"33","author":"Yin","year":"2022","journal-title":"Mamm. Genome"},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib208","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","article-title":"Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity","volume":"171","author":"Ying","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154809_bib209","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","article-title":"High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH","volume":"42","author":"Yoneda","year":"2007","journal-title":"J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib210","first-page":"E419","article-title":"SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity","volume":"298","author":"Yoshizaki","year":"2010","journal-title":"metabolism"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib211","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta\u2010analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib212","first-page":"262","article-title":"The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population","volume":"24","author":"Zelber-Sagi","year":"2012","journal-title":"hepatology"},{"issue":"9","key":"10.1016\/j.prp.2023.154809_bib213","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.2893","article-title":"Multigenerational epigenetic adaptation of the hepatic wound-healing response","volume":"18","author":"Zeybel","year":"2012","journal-title":"Nat. Med."},{"issue":"48","key":"10.1016\/j.prp.2023.154809_bib214","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2023.154809_bib215","first-page":"9","article-title":"Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway","volume":"73","author":"Zhang","year":"2017"},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib216","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13479","article-title":"Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur. J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.prp.2023.154809_bib217","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.18632\/aging.103020","article-title":"Ultraconserved element uc. 333 increases insulin sensitivity by binding to miR-223","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib218","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11596-019-1997-3","article-title":"Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3\/AMPK\/ACC Pathway","volume":"39","author":"Zhang","year":"2019","journal-title":"Curr. Med Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154809_bib219","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jhep.2015.07.037","article-title":"Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice","volume":"63","author":"Zhang","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05383-2","article-title":"Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2023.154809_bib222","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.29238","article-title":"SIRT1\/HSF1\/HSP pathway is essential for exenatide\u2010alleviated, lipid\u2010induced hepatic endoplasmic reticulum stress.","volume":"66","author":"Zheng","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.prp.2023.154809_bib223","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1159\/000495898","article-title":"Resveratrol ameliorates lipid droplet accumulation in liver through a SIRT1\/ ATF6-dependent mechanism","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"9","key":"10.1016\/j.prp.2023.154809_bib224","article-title":"Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease","volume":"38","author":"ZHU","year":"2022","journal-title":"J. Clin. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2023.154809_bib225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpg.2011.02.007","article-title":"Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases","volume":"25","author":"Zimmer","year":"2011","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prp.2023.154809_bib226","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-022-00889-7","article-title":"LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease","volume":"8","author":"Zou","year":"2022","journal-title":"Cell Death Discov."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823005095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823005095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:01:29Z","timestamp":1759734089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823005095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":226,"alternative-id":["S0344033823005095"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154809","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154809"}}